Molina Healthcare, Inc.

MOH · Healthcare

$197.20
+0.60% today

What a holder would want to know before buying MOH: where the price sits in its own history, how far it has fallen before and whether it recovered, and what the business behind it earns. All of it is arithmetic over free market data — no opinions, no recommendations.

Where the price sits
Low $122.65 · Feb 2026High $242.88 · Jul 2026

Today’s price is 61% above the lowest point of the past year and 19% below the highest.

Over the past year it was cheaper than today on 74% of days and more expensive on 26%. Over the last 10 years: cheaper on 51% of days.

8% above its average price of the last 200 trading days.

How bad does it get

Fell 20% or more 10 times in 10 years. The deepest fall was 71%; the longest took 14 months to get back to its peak. 9 of 10 have recovered so far.

It is in one now: 53% below the Mar 2024 peak.

Mar 2024
−71%not back yet
Oct 2022
−29%back in 14 months
Apr 2022
−28%back in 5 months
Aug 2020
−22%back in 2 months
Jun 2019
−31%back in 10 months
Sep 2018
−31%back in 8 months
and 4 earlier
What you own

Molina Healthcare, Inc. · Healthcare · Healthcare Plans · a large company worth $10.28B

Molina Healthcare, Inc. provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces in the United States. It operates…

Is it making money?
2022
2023
2024
2025

revenue profit

Sales of $45.43B in 2025, with $472.00M of profit. Sales grew in 3 of the last 3 years.

Loses money on its sales at the moment.

Is it healthy?
Cash
$8.92B
Debt
$3.95B
Free cash flow / yr
$700.25M

Would need about 5.6 years of free cash flow to repay all its debt.

Is it expensive?

You pay $2188 for every $1 of last year’s profit, and $20 for every $1 of profit expected next year.

A high number means buyers expect growth; a low one means they expect little, or fear trouble. Large US companies have averaged roughly 15–20 over the decades.

Pays no dividend.

What others are doing

19 analysts: 4 say buy, 14 hold, 1 sell. Their average 12-month target is $209.12 (range $147.00–$266.00).

Insiders made 0 purchases and 2 sales in the last 6 months. Executives routinely sell shares they were paid in; buying with their own money is the rarer signal.

Free data from Yahoo Finance, refreshed daily. This is evidence about the business and its price history, not a recommendation.

Now try it without risking anything

Poshkan is paper trading: real prices, virtual money. Buy MOH with $10,000 that isn’t real, set a stop before you enter, and find out what your idea would actually have done.

Data from Yahoo Finance, refreshed hourly. Nothing here is financial advice. Poshkan is a paper-trading simulator — all money, trades and returns are virtual.